SS-31 · Longevity
SS-31 dosage by bodyweight
Reference dose ranges scaled across bodyweight bands, anchored to the most-cited research dose (10000 mcg @ 75 kg). Educational only — never a recommendation.
| Bodyweight band | Reference dose range | At U-100 (1 mg/mL) | Vol. on U-100 (5 mg / 2 mL) | 5× t½ elapsed |
|---|---|---|---|---|
| <60 kg / <132 lb | 6233–8433 mcg | 6.23–8.43 mL | 249–337 units2.49–3.37 mL | 20 h |
| 60–75 kg / 132–165 lb | 7650–10350 mcg | 7.65–10.35 mL | 306–414 units3.06–4.14 mL | 20 h |
| 75–90 kg / 165–198 lb | 9350–12650 mcg | 9.35–12.65 mL | 374–506 units3.74–5.06 mL | 20 h |
| 90–105 kg / 198–231 lb | 11050–14950 mcg | 11.05–14.95 mL | 442–598 units4.42–5.98 mL | 20 h |
| >105 kg / >231 lb | 12750–17250 mcg | 12.75–17.25 mL | 510–690 units5.10–6.90 mL | 20 h |
Volume column assumes a standard 5 mg vial reconstituted with 2 mL bacteriostatic water (concentration 2.5 mg/mL); insulin units shown for a U-100 syringe. Five half-lives is the conventional washout window where ~3% of peak plasma remains — a useful "next dose due" anchor for SS-31 (t½ 4 h).
SS-31 by goal
Read SS-31's profile and dosing through a specific research-goal lens.
⚠
Educational use only
This calculator is provided for research and educational purposes. Outputs are derived from the values you enter. Always verify your math and consult a licensed physician before acting on any result.